WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2015

Nov 30, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2015-11-25

Reporting Person: Paproski John E (President-Delivery Systems)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-11-25	Common Stock	M	17560.0000	$22.4850	Acquired	87848.4314	Direct
2015-11-25	Common Stock	S	17560.0000	$63.4096	Disposed	70288.4314	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-11-25	Stock Option (Right to Buy)	$22.4850	M	17560.0000	Disposed	2018-02-27	Common Stock (17560.0000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	70288.4314	Direct
Common Stock	1357.4947	Indirect
Common Stock	24342.2087	Indirect

Footnotes

F1: Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.